InspireMD (NSPR) Cash & Current Investments (2010 - 2025)

InspireMD has reported Cash & Current Investments for 16 years, with the latest figure at $54.2 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments rose 56.51% year-over-year to $54.2 million; the trailing twelve-month figure through Dec 2025 stood at $54.2 million (up 56.51% YoY), and the FY2025 full-year result was $54.2 million, up 56.51% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $54.2 million, down from $63.4 million in the prior quarter.
• The five-year high for Cash & Current Investments was $63.4 million in Q3 2025, with the low at $12.9 million in Q1 2023.
• Historically, Cash & Current Investments has averaged $35.3 million across 5 years, with a median of $35.9 million in 2021.
• Annual changes were most pronounced in 2021 — Cash & Current Investments jumped 1301.91% — and 2025, when it tumbled 58.92%.
• InspireMD's Cash & Current Investments stood at $34.0 million in 2021, then sank by 47.7% to $17.8 million in 2022, then surged by 119.19% to $39.0 million in 2023, then decreased by 11.24% to $34.6 million in 2024, then surged by 56.51% to $54.2 million in 2025.
• The last three Cash & Current Investments figures came in at $54.2 million (Q4 2025), $63.4 million (Q3 2025), and $19.4 million (Q2 2025), per Business Quant data.